Literature DB >> 17342642

Antibiotic prophylaxis and the risk of surgical site infections following total hip arthroplasty: timely administration is the most important factor.

Marjo E E van Kasteren1, Judith Manniën, Alewijn Ott, Bart-Jan Kullberg, Annette S de Boer, Inge C Gyssens.   

Abstract

BACKGROUND: Surgical site infections (SSIs) following total hip arthroplasty can lead to prolonged hospitalization, increased morbidity and mortality, and high costs. This article analyzes the effect of various parameters of surgical antibiotic prophylaxis on the risk of SSI following total hip arthroplasty.
METHODS: Data about SSI and potential prophylaxis-, patient-, and procedure-related risk factors were prospectively collected for 1922 patients who underwent elective total hip arthroplasty in 11 hospitals that participated in the Dutch intervention project, Surgical Prophylaxis and Surveillance. Multivariate logistic regression analysis was performed to correct for random variation among hospitals.
RESULTS: SSIs (superficial and deep) occurred in 50 patients (2.6%). The highest odds ratios for SSI were found in patients who received prophylaxis after incision (2.8, 95% confidence interval [CI], 0.9-8.6; P=.07), had an American Society of Anesthesiology score that was >2 (2.8, 95% CI, 0.8-9.2; P=.09), and experienced a duration of surgery that was >75th percentile (2.5; 95% CI, 1.1-5.8; P=.04). Prolonged prophylaxis after the end of surgery and the use of antibiotic-impregnated cement did not contribute to fewer SSIs in this study.
CONCLUSIONS: This study suggests that intervention programs in search of amendable factors to prevent SSI should focus on timely administration of antibiotic prophylaxis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17342642     DOI: 10.1086/512192

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  55 in total

1.  Arthroplasty and postoperative antimicrobial prophylaxis.

Authors:  Andrew M Morris; Jeffrey Gollish
Journal:  CMAJ       Date:  2015-10-05       Impact factor: 8.262

2.  [Treatment algorithm for periprosthetic infections of the knee joint].

Authors:  C Lüring; S W Lemmen; V Quack; J Beckmann; M Tingart; B Rath
Journal:  Orthopade       Date:  2012-01       Impact factor: 1.087

3.  The Otto Aufranc Award: Modifiable versus nonmodifiable risk factors for infection after hip arthroplasty.

Authors:  Guy Maoz; Michael Phillips; Joseph Bosco; James Slover; Anna Stachel; Ifeoma Inneh; Richard Iorio
Journal:  Clin Orthop Relat Res       Date:  2015-02       Impact factor: 4.176

4.  Nonconcordance with surgical site infection prevention guidelines and rates of surgical site infections for general surgical, neurological, and orthopedic procedures.

Authors:  Barnaby Young; Tat Ming Ng; Christine Teng; Brenda Ang; Hwei Yee Tai; David C Lye
Journal:  Antimicrob Agents Chemother       Date:  2011-08-08       Impact factor: 5.191

5.  Effectiveness of an information technology intervention to improve prophylactic antibacterial use in the postoperative period.

Authors:  Kevin Haynes; Darren R Linkin; Neil O Fishman; Warren B Bilker; Brian L Strom; Eric A Pifer; Sean Hennessy
Journal:  J Am Med Inform Assoc       Date:  2011-01-24       Impact factor: 4.497

6.  [Prophylactic antibiotherapy in hip arthroplasty. Cohort study].

Authors:  M Garrote-Garrote; J A Del-Moral-Luque; A Checa-García; J F Valverde-Cánovas; C Campelo-Gutiérrez; J Martínez-Martín; A Gil-de-Miguel; G Rodríguez-Caravaca
Journal:  Rev Esp Quimioter       Date:  2018-03-14       Impact factor: 1.553

7.  A superficial swab culture is useful for microbiologic diagnosis in acute prosthetic joint infections.

Authors:  Jordi Cuñé; Alex Soriano; Juan C Martínez; Sebastián García; Josep Mensa
Journal:  Clin Orthop Relat Res       Date:  2008-10-11       Impact factor: 4.176

8.  Treatment solutions are unclear for perimegaprosthetic infections.

Authors:  Lisa B Ercolano; Tyson Christensen; Richard McGough; Kurt Weiss
Journal:  Clin Orthop Relat Res       Date:  2013-10       Impact factor: 4.176

9.  Inadequate timing of prophylactic antibiotics in orthopedic surgery. We can do better.

Authors:  Anna Stefánsdóttir; Otto Robertsson; Annette W-Dahl; Sverrir Kiernan; Pelle Gustafson; Lars Lidgren
Journal:  Acta Orthop       Date:  2009-12       Impact factor: 3.717

10.  Timing of surgical antibiotic prophylaxis administration: complexities of analysis.

Authors:  Carrie Cartmill; Lorelei Lingard; Glenn Regehr; Sherry Espin; John Bohnen; Ross Baker; Lorne Rotstein
Journal:  BMC Med Res Methodol       Date:  2009-06-23       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.